TGA has been a partner in Project Orbis Latest News TGA has been a partner in Project Orbis By Biotech Regulatory Solutions|2022-12-14T10:27:19+11:00February 20, 2022|Latest News|
TGA Summary of the regulation of Personal Protective Equipment and COVID-19 Latest News TGA Summary of the regulation of Personal Protective Equipment and COVID-19 By Biotech Regulatory Solutions|2022-12-14T10:27:20+11:00December 9, 2021|Latest News|
TGA Priority Review for Prescription Medicines By Biotech Regulatory Solutions|2022-12-14T10:27:21+11:00June 18, 2019|Latest News|
TGA Issues new Therapeutic Goods Order – TGO 101 (Standard for tablets, capsules and pills) By Biotech Regulatory Solutions|2022-12-14T10:27:23+11:00May 14, 2019|Latest News|
TGA has posted Important Dates for Sponsors of therapeutic goods for fees (Annual fees, exemptions) By Biotech Regulatory Solutions|2022-12-14T10:27:24+11:00May 13, 2019|Latest News|
Management and communication of medicine shortages and discontinuations in Australia By Biotech Regulatory Solutions|2022-12-14T10:27:25+11:00May 9, 2019|Latest News|
Favourite CRO, Consultancy or Partner – Biotech Regulatory Solutions Pty Ltd By Biotech Regulatory Solutions|2022-12-14T10:27:26+11:00August 31, 2017|Latest News|
TGA Regulatory Affairs Consultants By Biotech Regulatory Solutions|2022-12-14T10:27:28+11:00August 29, 2017|Latest News|
TGA Pharmacovigilance Inspections – starting 2017 By Biotech Regulatory Solutions|2022-12-14T10:27:29+11:00August 24, 2017|Latest News|
Australia’s 1st monoclonal antibody biosimilar approved by the TGA By Biotech Regulatory Solutions|2022-12-14T10:27:31+11:00August 29, 2015|Latest News|
